The first trial accusing Merck of withholding information on the dangers of osteoporosis drug, Fosamax, has ended in a mistrial after Juror No. 5 says she was intimidated and threatened by the other seven jurors for siding with the plaintiff.
The gold standard blood-thinners, used for heart attack and stroke, may be rivaled by an experimental drug, Brilinta, which causes less bleeding and increases the chance of survival.
The Watchman, a new device implanted in the heart, proved to be a potential alternative to a warafin, a standard blood thinner for helping patients with atrial fibrillation to prevent stroke.
Popular bone-building medications known as bisphosphonates may have a rare, but serious, cardiac side effect. A review of available research found these medications may increase the risk of atrial fibrillation -- a disorder that affects as many as 2.2 million Americans.
In yet another study, Fosamax is linked to the risk of developing atrial fibrillation, an irregular heart beat. But researchers conclude that the benefits of drugs in this class that fight the ravages of osteoporosis, outweigh the risks.
Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery. We are committed to serving the public with honesty and integrity in these efforts.
On the Road
Major Medical
Protecting Your Family
In the Workplace
Motley Rice Ranked A Best Law Firm by U.S. News and World Report
Tampa Toddler Dies After Being Left In Vehicle
Burn Advocates Network Returns From Mission In Haiti
Update: Burn Advocates Network In Haiti
Burn Advocates Network In Haiti